Impact of extended-course oral nirmatrelvir/ritonavir (Paxlovid) in established Long COVID: Case series and research considerations.

Autor: Cohen AK; University of California San Francisco & Patient-Led Research Collaborative., Jaudon TW; Patient-Led Research Collaborative & University of Arkansas for Medical Sciences., Schurman EM, Kava L; Patient-Led Research Collaborative., Vogel JM; Scripps Research Translational Institute and Patient-Led Research Collaborative., Haas-Godsil J, Lewis D; Patient-Led Research Collaborative., Crausman S, Leslie K, Bligh SC, Lizars G, Davids JD, Sran S, Peluso MJ; University of California San Francisco., McCorkell L; Patient-Led Research Collaborative.

Publikováno v: Research square [Res Sq] 2023 Sep 20. Date of Electronic Publication: 2023 Sep 20.